Abstract-Interactions of several
Materials and Methods
Male albino rabbits weighing 2.0 to 3.0 kg were killed by bleeding from the neck. Pieces (about 2 x 10 mm) of ciliary body were carefully dissected in a plane parallel to the iris (circular strip) from the enucleated eyeball, and they were mounted in a 20 ml of organ bath containing Krebs solution (118 mM NaCl, 1.2 mM MgCl2, 1.19 mM KH2PO4, 25 mM NaHCO3, 2.54 mM and 11 mM glucose)
at 32'C and gassed with 5% C02-95% 02. The preparations were sus pended under 20 to 30 mg tension, and responses were recorded via isometric transducers.
The preparations were allowed to equilibrate for at least 60 min before addition of any drugs. After the equilibration, the preparations were exposed to a sub maximum dose of carbachol, then washed throughly.
After an additional 30 min of equilibration, three cumulative concen centration-response curves to carbachol were determined.
In each preparation, when the last two concentration-response curves were similar, all subsequent results were compared with the last of those curves. Responses were expressed as a percentage of the maximum contractile response to carbachol. The agonistic activities of full and partial agonists were expressed as pD2 values, the negative log concentration (M) which produced 50% of the maximum contractions obtained from individual concentration-response curves. The pD2 values of full and partial agonists were calculated by the table of van Rossum (10). Antagonistic activity of each antagonist was measured against carbachol. The preparation was allowed to equilibrate with each concen tration of antagonist for 5 min before concen tration-response curves of carbachol were obtained, and pA2 values, the dissociation constant of the antagonist, were calculated according to the method of Arunlakshana and Schild (11 ). The intrinsic activities (i.a.) of partial agonists were expressed as the ratio between the maximum response to a test drug and that to carbachol. The pA2 values of partial agonists were calculated from the estimated difference between the curves from the full agonist (carbachol) alone and with the partial agonists according to the method of van Rossum (10).
Since pD2 values may not be a reliable measure of the actual affinities of full agonists, the dissociation constant of carbachol was determined according to the method of Furchgott and Bursztyn (12), using the irreversible antagonist phenoxybenzamine to occlude a fraction of muscarinic receptors. After the determination of the control concen tration-response curves of carbachol, the preparations were treated with 3x`10-6 M of phenoxybenzamine for 10 min. The pre parations were then allowed to re-equilibrate for 60 min, with repeated washing every 10 min, and second cumulative concentration response curves of carbachol were deter mined. The dissociation constant of carbachol was calculated from the following equation: 
The dissociation constant of the partial agonist was also obtained by the method of Furchgott and Bursztyn (12), in which the partial agonist serves as a competitive antagonist to carbachol (full agonist) after partial irreversible blockade of muscarinic receptors with phenoxybenzamine.
This treat ment reduces the response to the partial agonist to a greater extent than that to the full agonist, thereby the response to the partial agonist is insignificant with respect to that to the full agonist. Under these circum stances, the partial agonist may be used as a competitive antagonist, and pA2 values of partial agonists were estimated by the method of van Rossum (10) using carbachol as the agonist.
The pretreatment period of the partial agonist was 5 min in these experiments.
Fractional receptor occupancy for agonist and partial agonist at each concentration
[A] was calculated from the following equation:
where [RA] is the concentration of receptor agonist complex, [RT] is the total receptor concentration and KA is the dissociation constant of the agonist and partial agonist determined by the procedures described previously.
Drugs used: carbachol chloride, arecoline hydrochloride, pilocarpine hydrochloride, atropine sulfate and oxotremorine sesqui fumarate were from Sigma; phenoxybenza mine hydrochloride and hexamethonium dibromide was from Tokyo-Kasei; and nicotine bitartrate was from Nakarai, all in powder form. All drugs were used as solutions in distilled water. Other chemicals used were of analytical grade. Each point represents a mean with S.E. of 6 experiments.
Schild plots for an antagonism between atropine and carbachol (right). Ordinate, logarithms of equieffective concentration ratios of carbachol minus 1: abscissa, negative log concentrations of atropine. The slope of the line is 1.08±0.15.
Results
The ciliary body smooth muscles responded to carbachol with concentration-dependent contractions.
The Fig. 5-right) . Pretreatment of pilocarpine (3x10-4 M) also protected against the loss of contractile response to carbachol (data not shown). Therefore, the decrease of response of the ciliary body preparations to carbachol should be due to the irreversible blockade of the muscarinic receptors. 
Discussion
It is generally accepted that the iris ciliary body smooth muscles respond to several muscarinic agonists in a characteristic manner (3-5). In the present study, the rabbit ciliary body smooth muscles also responded to carbachol, a muscarinic full agonist, with concentration-dependent contractions. How ever, oxotremorine and arecoline, which act as full agonists in other peripheral tissues such as guinea pig ileum (13) as pA2 values versus carbachol estimated by the partial irreversible blockade of muscarinic receptors were also practically equal to those obtained in other tissues (8, 13, 16). Moreover, the pA2 value of 5.17 for pilocarpine obtained as a competitive antagonist versus carbachol in the ciliary body smooth muscle was nearly equal to that in the rabbit fundus strip (12) (negative log KA=5.2) where the drug behaved as an agonist, and the pA2 value of atropine versus carbachol obtained with the Schild plot analysis was practically equal to that in the rat intestine (pA2=8.9) reported by van Rossum (10). When the respective affinities of several agonists and antagonists are the same in different tissues, it is assumed that the drugs are interacting with the same receptor population
(1 1 ). Conversely, differences in affinities imply interaction with different receptor populations. Therefore, all these results suggest that in these tissues, the muscarinic receptors are of the same type.
Stephenson introduced the concept of the efficacy (e) which determines the magnitude of stimulus produced by the agonist for any given fraction of receptor occupancy (17). Furchgott and Bursztyn modified this model to differentiate the drug and tissue factors of efficacy by defining intrinsic efficacy (a). The relationship between the efficacy and the intrinsic efficacy was expressed by the following equation:
e=s-[RT] The intrinsic efficacy was strictly a drug related parameter which should be constant for the same type of receptor across species and tissues. Therefore, it is assumed that the difference between the efficacies (e) of the same drug which acts on the same type receptor population among the different tissues is the result of a different [RT] . In the rabbit ciliary body smooth muscles, the difference between the pD2 values and the negative log KA for carbachol was small, that is, efficacy (e) of carbachol in this tissue was 5.59+0.86, indicating a smaller muscarinic receptor reserve for carbachol than those other peripheral tissues, because the efficacies (e) of carbachol in the rabbit fundus strip and in the reserpinized left atrium of guinea pig were 190 to 266 and 50 to 87, respectively (12). In actuality, it was estimated that for carbachol, about 90% receptor occupancy was required to elicit a 100% response (Fig. 8) (18, 19) . Therefore, the stimuli induced by a partial agonist with lower intrinsic efficacy such as pilocarpine can not reach the threshold level, even if the drug occupies all the muscarinic receptors in the rabbit ciliary body smooth muscles; that is, pilocarpine behaved as a competitive antagonist in this tissue, and the pA2 values of oxotremorine and arecoline differed from their pD2 values. In order to determine the threshold to induce contraction, occupancy-response curves for oxotremorine and arecoline were extrapolated toward the y-axis. The y-intercept of the occupancy-response curve for oxotremorine was about minus 17%, and this value was virtually equal to that for arecoline (Fig. 8) 
